| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
427,496 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
216,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Abt John |
Chief Quality and Operations |
• – – |
2020-04-30 |
4 |
D |
$9.54 |
$5,123 |
D/D |
(537) |
47,104 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2020-03-31 |
4 |
A |
$5.91 |
$7,210 |
D/D |
1,220 |
48,337 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2020-03-31 |
4 |
A |
$5.91 |
$3,806 |
D/D |
644 |
70,247 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2020-03-31 |
4 |
A |
$5.91 |
$6,921 |
D/D |
1,171 |
187,738 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2020-03-31 |
4 |
A |
$5.91 |
$4,090 |
D/D |
692 |
47,641 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2019-12-31 |
4 |
A |
$7.50 |
$4,440 |
D/D |
592 |
69,603 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-12-31 |
4 |
A |
$7.50 |
$4,778 |
D/D |
637 |
46,949 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2019-11-12 |
4 |
D |
$8.98 |
$13,353 |
D/D |
(1,487) |
37,686 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2019-11-11 |
4 |
AB |
$8.99 |
$17,980 |
D/D |
2,000 |
186,567 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2019-11-09 |
4 |
D |
$8.93 |
$1,982 |
D/D |
(222) |
50,459 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2019-11-09 |
4 |
D |
$8.93 |
$3,018 |
D/D |
(338) |
47,117 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2019-11-09 |
4 |
D |
$8.93 |
$1,982 |
D/D |
(222) |
39,173 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-11-09 |
4 |
D |
$8.93 |
$2,474 |
D/D |
(277) |
46,312 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2019-10-26 |
4 |
D |
$11.87 |
$8,499 |
D/D |
(716) |
50,681 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2019-09-30 |
4 |
A |
$5.14 |
$3,742 |
D/D |
728 |
69,011 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2019-09-30 |
4 |
A |
$5.14 |
$3,511 |
D/D |
683 |
184,567 |
|
- |
|
| Ehlinger Robert |
VP and CIO |
• – – |
2019-09-30 |
4 |
A |
$5.14 |
$2,791 |
D/D |
543 |
47,455 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2019-09-30 |
4 |
A |
$5.14 |
$4,030 |
D/D |
784 |
46,589 |
|
- |
|
| Landis G. Michael |
Principal Accounting Officer |
• – – |
2019-09-22 |
4 |
D |
$5.00 |
$380 |
D/D |
(76) |
39,395 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2019-09-22 |
4 |
D |
$5.00 |
$475 |
D/D |
(95) |
51,397 |
|
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2019-09-09 |
4 |
S |
$12.54 |
$203,085 |
D/D |
(16,195) |
45,945 |
|
- |
|
| Paonessa Albert Iii |
Director |
– • – |
2019-09-06 |
4 |
S |
$10.30 |
$119,295 |
D/D |
(11,582) |
62,140 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2019-09-03 |
4 |
B |
$9.82 |
$245,500 |
D/D |
25,000 |
201,340 |
2.39 |
- |
|
| Galvan Martin P |
Former VP of Finance & CFO |
• – – |
2019-08-30 |
4 |
D |
$10.30 |
$423,073 |
D/D |
(41,075) |
102,409 |
|
- |
|
| Galvan Martin P |
Former VP of Finance & CFO |
• – – |
2019-08-30 |
4 |
A |
$0.00 |
$0 |
D/D |
46,342 |
143,484 |
|
- |
|
762 Records found
|
|
Page 6 of 31 |
|
|
